Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Clearside Biomedical, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 46 | 48 | +2 |
| Shares | 7.84M | 7.75M | −91.8K (−1.2%) |
| Value | $6.82M | $9.06M | +$2.24M (+32.9%) |
New holders (9)
Institutions that held Clearside Biomedical, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Natixis | 47,500 | $55.6K | 0.00% |
| Millennium Management LLC | 33,638 | $39.4K | 0.00% |
| Newman Dignan & Sheerar, Inc. | 28,023 | $32.8K | 0.01% |
| Mariner, LLC | 18,950 | $22.2K | 0.00% |
| Virtu Financial LLC | 17,513 | $20.0K | 0.00% |
| Huntington National Bank | 500 | $585 | 0.00% |
| Scarborough Advisors, LLC | 277 | $324 | 0.00% |
| Creative Financial Designs Inc | 100 | $117 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 385 | $0 | 0.00% |
Sold out (7)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Water Island Capital LLC | 82,500 | $71.8K |
| Assenagon Asset Management S.A. | 71,776 | $62.4K |
| Two Sigma Advisers, LP | 62,900 | $54.7K |
| Signaturefd, LLC | 54,177 | $47.1K |
| Stratos Wealth Partners, LTD. | 31,442 | $27.4K |
| Acadian Asset Management LLC | 17,536 | $15.0K |
| Group One Trading, L.P. | 1,587 | $1.38K |